الصفحة الرئيسية>>Signaling Pathways>> Stem Cell>> Wnt/β-catenin>>Tankyrase Inhibitors (TNKS) 22

Tankyrase Inhibitors (TNKS) 22 (Synonyms: TNKS 22;TNKS22;TNKS-22)

رقم الكتالوجGC15041

Tankyrase inhibitor

Products are for research use only. Not for human use. We do not sell to patients.

Tankyrase Inhibitors (TNKS) 22 التركيب الكيميائي

الحجم السعر المخزون الكميّة
5mg
148٫00
متوفر
10mg
239٫00
متوفر
50mg
715٫00
متوفر
100mg
1082٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

Tankyrase Inhibitors (TNKS) 22 is a potent, selective and orally bioavailable inhibitor of tankyrase with IC50 value of 0.1nM [1].

Tankyrase 1 and tankyrase 2 are members of PARP family. They can use NAD+ as substrates to transfer ADP-ribose polymers onto tagert proteins. The tankyrase are found to bind to PARSylate axin proteins which are the negative regulator of Wnt pathway. It makes tankyrase to be targets in treatment for adenomatous polyposis coli. Tankyrase inhibitors 22 is an optimization of the previous hit compound inhibitor 8 with improved potency and selectivity. It has excellent effects in both tankyrase assay and cellular assay (total β-catenin degradation assay in SW480 cells) with IC50 values of 0.1nM and 3.7nM, respectively. In addition, it is found to be a dual binder with both the nicotinamide pocket and the induced pocket of the enzymes [1].

In the in vivo studies in rodents, tankyrase inhibitors 22 is found to potently inhibit TNKS2 autoparsylation with IC50 value of 4.1nM. It also causes stabilization and accumulation of axin protein in SW480 cells with EC50 value of 3.9nM. In DLD-1 cells with truncated APC, the inhibitor inhibits the STF reporter transcription with IC50 value of 0.6nM suggesting its downstream inhibitory activity on Wnt-associated transcription [1].

References:
[1] Hua Z, Bregman H, Buchanan J L, et al. Development of Novel Dual Binders as Potent, Selective, and Orally Bioavailable Tankyrase Inhibitors. Journal of medicinal chemistry, 2013, 56(24): 10003-10015.

مراجعات

Review for Tankyrase Inhibitors (TNKS) 22

Average Rating: 5 ★★★★★ (Based on Reviews and 34 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Tankyrase Inhibitors (TNKS) 22

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.